ADVANCED RESEARCH AND DEVELOPMENT Solicitation ID/Procurement Identifier: 80ARC023R0001 Ultimate Completion Date: Wed Sep 27 17:00:00 GMT 2028
We appreciate your interest in partnering with BARDA.The latest BARDA Broad Agency Announcement (BAA) is Amendment 3 posted on March 29, 2024.All contracting-related inquiries should be sent to BARDA-BAA@hhs.gov.The final proposal submission deadline is September 25, 2028, at 4:30 PM Eastern Time for open areas of interest.
agreements, and enter into other transactions, for countermeasure and product advanced research and development.
ADVANCED RESEARCH AND DEVELOPMENT ACTIVITIES FOR NOVEL IMMUNOGENICITY ASSAYS AND SAMPLE COLLECTION TECHNOLOGIES AS PART OF BARDA?S CONTINUING SUPPORT FOR COVID-19 VACCINE DEVELOPMENT, ASSESSING IMPACT... Solicitation ID/Procurement Identifier: 75A50123C00045 Ultimate Completion Date: Mon Sep 28 17:00:00 GMT 2026
agreements, and enter into other transactions, for countermeasure and product advanced research and development.
The Food and Drug Administration (FDA) solicits for advanced research and development proposals to support regulatory science and innovation. The FDA anticipates that research and development activities under this Broad Agency Announcement (BAA) will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation.
BARDA is interested in learning more about the requested laboratory servicesthat will support advanced research and development of influenza virus vaccinesand emerging infectious diseases vaccines, including support for Phase 1, 2, and 3 clinical trial endpoints?.
